Literature DB >> 29580147

Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review.

Hui Luo1,2, Liangqun Peng3, Nan Wang2, Jiangong Zhang2, Xiaoli Zheng2, Yanan Sun2, Chengcheng Fan2, Hong Ge2.   

Abstract

Advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy and surgery followed by early brain metastasis is rare. A 52-y-old male patient who was diagnosed with advanced gastric cancer (cT4N2M0, stage ШB). Radiological examinations after three cycles of preoperative chemotherapy with a modified FOLFOX6 (mFOLFOX6) regimen showed a partial response (PR) had been achieved. The patient underwent curative surgery consisting of proximal gastrectomy, and D2 lymph node dissection. The lack of abnormal gastric cancer cells in the primary lesion or lymph nodes confirmed a pathological complete response (pCR). Postoperative chemotherapy with oral S-1 was administrated. However, during the second cycles of postoperative chemotherapy, the patient experienced headaches, projectile vomiting and convulsion. Upon further examination, a tumor representing metastasis to the brain was recognized by cranial enhanced magnetic resonance imaging (MRI) examination and cytopathology of cerebrospinal fluid. In addition to documenting the case report, we reviewed the literature associated to features of metastatic brain malignancies that form from gastric cancer. In short, advanced gastric cancer patents achieved pCR after preoperative chemotherapy typically have good prognosis; however, great attention should be paid on detecting metastatic events.

Entities:  

Keywords:  brain metastasis; gastric cancer; pathological complete response; preoperative chemotherapy

Mesh:

Substances:

Year:  2018        PMID: 29580147      PMCID: PMC6300339          DOI: 10.1080/15384047.2018.1456600

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Authors:  Marc Ychou; Valérie Boige; Jean-Pierre Pignon; Thierry Conroy; Olivier Bouché; Gilles Lebreton; Muriel Ducourtieux; Laurent Bedenne; Jean-Michel Fabre; Bernard Saint-Aubert; Jean Genève; Philippe Lasser; Philippe Rougier
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

Review 2.  Gastrointestinal cancer and brain metastasis: a rare and ominous sign.

Authors:  Pauline H Go; Zachary Klaassen; Michael C Meadows; Ronald S Chamberlain
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

3.  Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan.

Authors:  Miao Yu; Hua-chuan Zheng; Pu Xia; Hiroshi Takahashi; Shinji Masuda; Yasuo Takano; Hui-mian Xu
Journal:  Indian J Med Res       Date:  2010-09       Impact factor: 2.375

4.  Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats.

Authors:  Hui-Juan He; Yi Wang; Yuan Le; Kai-Ming Duan; Xue-Bin Yan; Qin Liao; Yan Liao; Jian-Bin Tong; Niccolò Terrando; Wen Ouyang
Journal:  CNS Neurosci Ther       Date:  2012-10-19       Impact factor: 5.243

5.  Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer.

Authors:  Jun Zhang; Ren-Xiong Chen; Jing Zhang; Jun Cai; Hua Meng; Guo-Cong Wu; Zhong-Tao Zhang; Yu Wang; Kang-Li Wang
Journal:  Chin Med J (Engl)       Date:  2012-06       Impact factor: 2.628

6.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

7.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

8.  Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.

Authors:  Takaki Yoshikawa; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Yutaka Kimura; Shinichi Hasegawa; Toru Aoyama; Tsutomu Hayashi; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
Journal:  Ann Surg Oncol       Date:  2014-03-05       Impact factor: 5.344

9.  Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.

Authors:  R C Fields; V E Strong; M Gönen; K A Goodman; N P Rizk; D P Kelsen; D H Ilson; L H Tang; M F Brennan; D G Coit; M A Shah
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

10.  A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Authors:  Yan Wang; Yi-yi Yu; Wei Li; Yi Feng; Jun Hou; Yuan Ji; Yi-hong Sun; Kun-tang Shen; Zhen-bin Shen; Xin-yu Qin; Tian-shu Liu
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-21       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.